Vanguard Group’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$8.09M Buy
8,416,971
+896,916
+12% +$1.27M ﹤0.01% 3070
2025
Q3
$13.1M Buy
7,520,055
+520,431
+7% +$1.02M ﹤0.01% 2829
2025
Q2
$14.6M Buy
6,999,624
+399,978
+6% +$768K ﹤0.01% 2710
2025
Q1
$11.3M Buy
6,599,646
+996,962
+18% +$3.74M ﹤0.01% 2779
2024
Q4
$28.3M Buy
5,602,684
+543,995
+11% +$2.69M ﹤0.01% 2417
2024
Q3
$27.5M Buy
5,058,689
+329,095
+7% +$2.17M ﹤0.01% 2441
2024
Q2
$22.7M Buy
4,729,594
+709,913
+18% +$3.69M ﹤0.01% 2508
2024
Q1
$12.5M Buy
4,019,681
+896,415
+29% +$3.01M ﹤0.01% 2840
2023
Q4
$8.87M Buy
3,123,266
+104,299
+3% +$268K ﹤0.01% 3016
2023
Q3
$8.85M Buy
3,018,967
+50,331
+2% +$167K ﹤0.01% 2950
2023
Q2
$8.49M Buy
2,968,636
+2,359
+0.1% +$8.5K ﹤0.01% 3040
2023
Q1
$9.17M Buy
2,966,277
+121,014
+4% +$344K ﹤0.01% 2983
2022
Q4
$6M Buy
2,845,263
+174,140
+7% +$529K ﹤0.01% 3216
2022
Q3
$8.71M Sell
2,671,123
-2,882
-0.1% -$11.1K ﹤0.01% 3015
2022
Q2
$8.58M Buy
2,674,005
+251,985
+10% +$1.4M ﹤0.01% 3075
2022
Q1
$17.1M Buy
2,422,020
+1,253,788
+107% +$7.3M ﹤0.01% 2859
2021
Q4
$8.47M Buy
1,168,232
+878,123
+303% +$8.69M ﹤0.01% 3311
2021
Q3
$3.37M Buy
+290,109
New +$3.32M ﹤0.01% 3869

Other funds holding HUMA